1-(4-bromophenyl)-1H-pyrrolo[2,3-c]pyridine | 1364440-86-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 英文名称: 1-(4-bromophenyl)-1H-pyrrolo[2,3-c]pyridine
• 英文别名: 1-(4-Bromophenyl)pyrrolo[2,3-c]pyridine
• CAS: 1364440-86-7
• 化学式: C₁₃H₉BrN₂
• 分子量: 273.132
• InChiKey: UWABWUQDHPOODF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  17.8
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  6-氮杂吲哚 、 对溴碘苯 在 potassium phosphate 、 copper(l) iodide 、 trans-N,N,N′,N'-tetramethylcyclohexane-1,2-diamine 作用下， 以 甲苯 为溶剂， 以15%的产率得到1-(4-bromophenyl)-1H-pyrrolo[2,3-c]pyridine
  参考文献：
  名称：

  New aromatase inhibitors from the 3-pyridyl arylether and 1-aryl pyrrolo[2,3-c]pyridine series

  摘要：

  Aromatase inhibition is the new standard of care for estrogen receptor positive breast cancer and has also potential for treatment of other diseases such as endometriosis. Simple and readily available 3-pyridyl arylethers and 1-aryl pyrrolo[2,3-c]pyridines recapitulating the key pharmacophore elements of Letrozole (1) are described and their structure-activity relationships are discussed. Potent and ligand efficient leads such as compound 23 (IC50 = 59 nM on aromatase) have been identified. (c) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.01.076

文献信息

• NEW COMPOUNDS
  申请人：Proximagen Limited

  公开号：US20150258101A1

  公开（公告）日：2015-09-17

  The present invention provides certain compounds according to formula (I) which are inhibitors of SSAO activity wherein V, W, X, Y, Z, R 1 and R 2 are as defined in the specification.

  本发明提供了一些按照式(I)的化合物，这些化合物是SSAO活性的抑制剂，其中V、W、X、Y、Z、R1和R2如规范中所定义。
• IMIDAZO[4,5-C]PYRIDINE AND PYRROLO[2,3-C]PYRIDINE DERIVATIVES AS SSAO INHIBITORS
  申请人：PROXIMAGEN LIMITED

  公开号：US20160046622A1

  公开（公告）日：2016-02-18

  The compounds of formula (I) are inhibitors of semicarbazide-sensitive amine oxidase (SSAO) activity useful in the treatment of inflammation, an inflammatory disease, an immune or an autoimmune disorder, or inhibition of tumour growth.

  式(I)的化合物是半卡巴肼敏感胺氧化酶（SSAO）活性的抑制剂，可用于治疗炎症、炎症性疾病、免疫或自身免疫性疾病，或抑制肿瘤生长。
• Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors
  申请人：PROXIMAGEN, LLC

  公开号：US10428066B2

  公开（公告）日：2019-10-01

  The compounds of formula (I) are inhibitors of SSAO activity wherein V, W, X, Y, Z, R1 and R2 are as defined in the claims.

  式（I）化合物是 SSAO 活性抑制剂 其中 V、W、X、Y、Z、R1 和 R2 如权利要求中所定义。
• Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors
  申请人：PROXIMAGEN, LLC

  公开号：US10766897B2

  公开（公告）日：2020-09-08

  The compounds of formula (I) are inhibitors of SSAO activity wherein V, W, X, Y, Z, R1 and R2 are as defined in the claims.

  式（I）化合物是 SSAO 活性抑制剂 其中 V、W、X、Y、Z、R1 和 R2 如权利要求中所定义。
• US9676769B2
  申请人：——

  公开号：US9676769B2

  公开（公告）日：2017-06-13